China Universal Asset Management Co., Ltd. Cogent Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 19,950 shares of COGT stock, worth $168,378. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,950
Previous 19,950
-0.0%
Holding current value
$168,378
Previous $134,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding COGT
# of Institutions
159Shares Held
102MCall Options Held
197KPut Options Held
102K-
Kynam Capital Management, LP Princeton, NJ8.5MShares$71.7 Million5.99% of portfolio
-
State Street Corp Boston, MA7.63MShares$64.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.69MShares$56.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct6.68MShares$56.3 Million0.11% of portfolio
-
Commodore Capital LP New York, NY6.43MShares$54.2 Million3.73% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $555M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...